Today’s articles on Sectors

Wells Fargo: Was That The Bottom? By Stone Fox Capital • 45 comments Outperforming High Dividend Stock Yields 12%, Upped Guidance, Estimates Rising By Double Dividend Stocks • 13 comments Visa's Dividend Potential Untapped By Valuentum • 11 comments Editors' Picks AMD's GPU Market Share Gains A Pyrrhic Victory By Mark Hibben Whiting Petroleum: Deleveraging Remains A Challenge By Richard Zeits Twitter's NFL Success? By David Pinsen Could There Be A Bubble Forming Mr. Zell? By Brad Thomas Campbell Soup: Still Too Hot To Eat By Economics-Based Investor More Editors' Picks» Basic Materials New York's Newest Exxon Mobil Probe Highlights The Flaws Of Its Previous Investigations by Tristan R. Brown What Royal Dutch Shell Is Doing To Solve LNG's Biggest Challenge by Gary Bourgeault Oasis Petroleum: A Step In The Right Direction by Richard Zeits Oasis Petroleum's New Convertible Notes: Do You Want All The Options? by Nikolai Gouliaev Agnico Eagle - Production Update On Amaruq Project In The Kivalliq- Nunavut, Northern Canada by Fun Trading More Basic Materials» Consumer Goods Where Does Nike Go From Here? CrossFit by Bradley Burk Can Boston Beer Get Its Groove Back? by Quinn Foley The Time Has Come (Finally) To Buy Under Armour by Fiver Capital Under Armour's New Direction Is Filled With Risks by Rohit Chhatwal Expensive On The Surface, Is Kraft Worth A Shot? by D.M. Martins Research More Consumer Goods» Financial Bank Of America: Know Why You Own It by FIG Ideas Update To PIMCO Closed-End Funds UNII - August 2016 by Alpha Gen Capital Royal Bank Of Scotland: Investors Head For The Exits On Deutsche Bank News by Michael Boyd Don't Let Me Down, Down, Down by Volatility Surfer AIG Is A Steal At $57 by Achilles Research More Financial» Healthcare 4 Reasons Pfizer Remains A Buy Today by Dividend Sensei Finally, Time To Buy Bristol-Myers by Casey Hoerth Abbott Laboratories - Reducing Leverage And Increasing Focus Following Vision Care Divestment by The Value Investor Inovio - First To Zika And MERS Vaccine Trials, Has 4 Near-Term Catalysts by Will Driscoll This Is The Biggest Reason To Buy Johnson & Johnson (Hint, It Has Nothing To Do With The Dividend) by Dividend Sensei More Healthcare» Industrial Goods Ingersoll-Rand: Margin Increase Is The Way To Earnings Growth, A Total Return Company by William Stamm More Industrial Goods» Services DryShips: The End Of The Road? by Fundamental Investing Walgreens Boots Alliance: Buffett-Like Appeal by Paul Price FedEx: Is The Stock Overrated Right Now? by Discount Fountain Starbucks Tea And Board Announcements Are Positive by Simple Qualitative Does Ruby Tuesday Know What It's Doing? by Quinn Foley More Services» Technology Cognizant Technology - A Rare Opportunity To Buy This Excellent Stock Cheap by Paul Price JD.com - Explore Chinese Rural Ecommerce Market Through Charity Project by Ivan.Tang Keep Buying BT Group by Casey Hoerth Sphere 3D Is Out Of Money And Can Go Much Lower by Orange Peel Investments Will Pandora Just Simply Die Off? by Orange Peel Investments More Technology» Please do not forward this email. It allows direct access to your Seeking Alpha Portfolio. Why are you receiving this? You subscribed to Sectors at Seeking Alpha. Unsubscribe from this email or manage all your Seeking Alpha email choices here. To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders. Sent by Seeking Alpha, 52 Vanderbilt Avenue, 13th floor, New York, NY 10017